Emmanuel Hanon, Vicebio CEO

UK vac­cine start­up Vice­bio snags $100M to take on GSK, Pfiz­er and Mod­er­na

The for­mer head of vac­cine R&D at GSK has pulled to­geth­er $100 mil­lion for a Lon­don-based biotech work­ing on res­pi­ra­to­ry vac­cines. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA